Alliance for Clinical Trials in Oncology

Alliance for Clinical Trials in Oncology logo
🇺🇸United States
Ownership
Private
Established
2011-01-01
Employees
251
Market Cap
-
Website
https://www.allianceforclinicaltrialsinoncology.org

Epratuzumab and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma

Phase 2
Completed
Conditions
Interventions
First Posted Date
2007-11-04
Last Posted Date
2016-07-06
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
60
Registration Number
NCT00553501
Locations
🇺🇸

CCOP - Northern Indiana CR Consortium, South Bend, Indiana, United States

🇺🇸

University of Illinois Cancer Center, Chicago, Illinois, United States

🇺🇸

University of Chicago Cancer Research Center, Chicago, Illinois, United States

and more 40 locations

Erlotinib and Gemcitabine With or Without Panitumumab in Treating Patients With Metastatic Pancreatic Cancer

First Posted Date
2007-10-30
Last Posted Date
2017-04-05
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
104
Registration Number
NCT00550836
Locations
🇺🇸

Hematology-Oncology Centers of the Northern Rockies - Billings, Billings, Montana, United States

🇺🇸

Northern Montana Hospital, Havre, Montana, United States

🇺🇸

Big Sky Oncology, Great Falls, Montana, United States

and more 254 locations

Cryoablation or External-Beam Radiation Therapy in Treating Patients With Painful Bone Metastases

First Posted Date
2007-10-08
Last Posted Date
2018-11-21
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
3
Registration Number
NCT00540969
Locations
🇺🇸

Mayo Clinic Cancer Center, Rochester, Minnesota, United States

🇺🇸

UAB Comprehensive Cancer Center, Birmingham, Alabama, United States

🇺🇸

Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States

and more 4 locations

Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery

Phase 2
Completed
Conditions
Interventions
First Posted Date
2007-08-27
Last Posted Date
2017-08-14
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
49
Registration Number
NCT00521001
Locations
🇺🇸

Meeker County Memorial Hospital, Litchfield, Minnesota, United States

🇺🇸

St. Mary - Corwin Regional Medical Center, Pueblo, Colorado, United States

🇺🇸

Memorial Hospital, Carthage, Illinois, United States

and more 192 locations

Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer

First Posted Date
2007-08-15
Last Posted Date
2016-07-13
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
140
Registration Number
NCT00516698
Locations
🇺🇸

Rush-Copley Cancer Care Center, Aurora, Illinois, United States

🇺🇸

Mason District Hospital, Havana, Illinois, United States

🇺🇸

Graham Hospital, Canton, Illinois, United States

and more 174 locations

Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

First Posted Date
2007-08-15
Last Posted Date
2017-08-24
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
208
Registration Number
NCT00516503
Locations
🇺🇸

Graham Hospital, Canton, Illinois, United States

🇺🇸

Galesburg Cottage Hospital, Galesburg, Illinois, United States

🇺🇸

Mercy Medical Center - Sioux City, Sioux City, Iowa, United States

and more 159 locations

Galiximab in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma

Phase 2
Completed
Conditions
Interventions
First Posted Date
2007-08-15
Last Posted Date
2016-07-06
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
30
Registration Number
NCT00516217
Locations
🇺🇸

University of Chicago Cancer Research Center, Chicago, Illinois, United States

🇺🇸

Galesburg Clinic, PC, Galesburg, Illinois, United States

🇺🇸

Perry Memorial Hospital, Princeton, Illinois, United States

and more 53 locations

Early or Delayed Fludarabine and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia

Phase 3
Terminated
Conditions
Interventions
First Posted Date
2007-08-09
Last Posted Date
2020-04-22
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
84
Registration Number
NCT00513747
Locations
🇺🇸

Virginia K. Crosson Cancer Center at St. Jude Medical Center, Fullerton, California, United States

🇺🇸

Providence Saint Joseph Medical Center - Burbank, Burbank, California, United States

🇺🇸

Camino Medical Group - Treatment Center, Mountain View, California, United States

and more 379 locations

Dasatinib in Treating Patients With Previously Treated Malignant Mesothelioma

Phase 2
Completed
Conditions
Interventions
First Posted Date
2007-07-31
Last Posted Date
2016-08-11
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
46
Registration Number
NCT00509041
Locations
🇺🇸

Memorial Hospital of South Bend, South Bend, Indiana, United States

🇺🇸

Center for Cancer Therapy at LaPorte Hospital and Health Services, La Porte, Indiana, United States

🇺🇸

Rebecca and John Moores UCSD Cancer Center, La Jolla, California, United States

and more 34 locations

Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer

Phase 3
Active, not recruiting
Conditions
Interventions
First Posted Date
2007-07-11
Last Posted Date
2024-10-26
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
701
Registration Number
NCT00499330
Locations
🇺🇸

Saint Mary Corwin Medical Center, Pueblo, Colorado, United States

🇦🇺

Saint Vincent's Hospital, Fitzroy, Victoria, Australia

🇺🇸

Allegheny General Hospital, Pittsburgh, Pennsylvania, United States

and more 382 locations
© Copyright 2024. All Rights Reserved by MedPath